Skip to main content
. Author manuscript; available in PMC: 2010 Jun 19.
Published in final edited form as: Vaccine. 2009 May 3;27(30):3945–3952. doi: 10.1016/j.vaccine.2009.04.040

Table 3.

Human Papillomavirus (HPV) vaccine barriers by focus group type

Barriers Healthcare Providers* Community Leaders* Parents Women
Healthcare
 Healthcare access, adequate number of providers +/− + + +
 Health insurance + + + +
 Provider-patient communication +/− +/− +/− +/−
General social and cultural
 Teenage pregnancy rates are high, smoking is common and accepted, poverty rates are high + + + +
 Poor parent – child communication +/− +/− +/− +/−
Financial issues
 Cost of vaccine, transportation + + +/− +
 Child care +
Concerns
 Lack of information about long term effectiveness, side effects (short- term and long-term), recommendation is for young girls + + + +
 Harm future reproductive capability + + +
*

Healthcare providers gave answers regarding their patients’ barriers and community leaders’ gave answers about community members’ barriers

(+):mentioned as a barrier; (−):mentioned as not being a barrier; (+/−):mentioned as being and not being a barrier; blank:not mentioned